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An outbreak of Enterobacter cloacae infections with
variable susceptibility to fluoroquinolones occurred in the
University Medical Center Utrecht in the Netherlands in
2002. Our investigation showed that a qnrA1 gene was
present in 78 (94%) of 83 outbreak isolates and that a
qnrA1-encoding plasmid transferred to other strains of the
same species and other species. The earliest isolate carry-
ing this same plasmid was isolated in 1999. qnrA1 was
located in a complex integron consisting of the intI1, aadB,
qacE∆1,  sul1,  orf513,  qnrA1,  ampR,  qacE∆1, and sul1
genes that were not described previously. On the same
plasmid, 2 other class 1 integrons were present. One was




including resistance to quinolones, is increasing.
Although quinolone resistance is predominantly caused by
chromosomal mutations, it may also result from a plasmid-
encoded  qnr-gene (1). The QnrA determinant, a
218–amino acid protein, protects DNAgyrase and topoiso-
merase IV from the inhibitory activity of quinolones (2).
However, expression of qnrA alone is frequently insuffi-
cient to reach Clinical and Laboratory Standards Institute
breakpoints for ciprofloxacin resistance. Since first identi-
fied in 1994 in the United States, qnrA-like genes have
been sporadically identified in Enterobacteriaceae world-
wide (3–9).
At the end of 2002, an outbreak of aminoglycoside-
resistant  Enterobacter cloacae infections with variable
susceptibility for ciprofloxacin was detected in the
University Medical Center Utrecht (UMCU), the
Netherlands, involving >80 patients (10). The first aim of
this study was to test the hypothesis that the variable
susceptibility to ciprofloxacin of the outbreak strain was
associated with plasmid-mediated qnrA and if so, to char-
acterize the gene’s molecular background and determine
its ability to transfer in vitro as well as in vivo. Maximum
circumstantial evidence for horizontal transfer in vivo with
the outbreak strain as donor would be obtained if the fol-
lowing observations were made: 1) different species or
strains collected from the same patient harbored the same
qnrA-encoding plasmid; 2) this same qnrA-encoding plas-
mid was not found in patients without an epidemiologic
link to the outbreak. The second aim of this study was to
determine to what extent the qnrA gene is an emerging
resistance problem in our hospital.
Materials and Methods
Bacterial Isolates
A total of 1,167 isolates were tested for a qnrA gene.
Group I consisted of 178 E. cloacae pulsed-field gel elec-
trophoresis (PFGE) typed isolates obtained from January
2001 to August 2003 from 159 patients (10). Of these, 83
tobramycin-resistant isolates obtained from 83 patients
belonged to 1 clonal lineage (cluster I, outbreak strain).
Five of these patients also carried a tobramycin-suscepti-
ble variant of the clonal lineage (IA). The remaining 95 E.
cloacae isolates contained 5 small clusters of 2 isolates
each (III–VII), 1 cluster with 6 isolates (VIII), 1 cluster
with 3 isolates (II), and 70 unique strains. 
Groups II and III consisted of aminoglycoside-resistant,
gram-negative bacteria identified in the hospital database
that were other than the outbreak strain; these bacteria
were isolated from patients with an outbreak strain (group
II) as well as from patients not involved in the outbreak but
admitted in the same period (January 2001–August 2003)
(group III). Aminoglycoside resistance was the selection
criterion because the outbreak strain was aminoglycoside-
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oratory. Group IV consisted of 867 Enterobacteriaceae
isolates comprising 8 different species collected from 3
different origins: 269 clinical isolates from UMCU
(1994–2000), 514 isolates from 23 European hospitals
(1997–1998), and 84 fecal screening isolates from 53
patients at admission at UMCU (2000) (11). 
Identification and Susceptibility Testing 
Identification and susceptibility testing of isolates
obtained through 2000 were performed by using the
VITEK1 System with AMS R09.1 software (bioMérieux,
Marcy-L’etoile, France); isolates obtained after 2000 were
tested by using the Phoenix 100 Automated Microbiology
System version V3.22 software (Becton Dickinson
Biosciences, Sparks, MD, USA). For susceptibility testing,
Clinical and Laboratory Standards Institute guidelines were
used (12). In the conjugation experiments, MICs were
determined by using Etest (AB Biodisk, Solna, Sweden).
Genotyping and Characterization of β β-Lactamases
E. cloacae isolates were typed by PFGE. Citrobacter
freundii,  Escherichia coli, and  Klebsiella pneumoniae
were typed by PFGE and random amplified polymorphic
DNA (13). To determine the kind of β-lactamases the out-
break strain expressed, isoelectric focusing (IEF) was per-
formed with Phastgels (pH gradient 3–9) with the
PhastSystem (Pharmacia AB, Uppsala, Sweden) (14). β-
lactamases of isoelectric pH (pI) 5.6 (TEM-1), pI 7.6
(SHV-2A), and pI 8.2 (blaCTX-M-9) and a broad range pI cal-
ibration set (Amersham Biosciences, Little Chalfont, UK)
were used. β-lactamases were detected with nitrocefin
(Oxoid, Basingstoke, UK).
Detecting and Characterizing Resistance Genes
Target DNA for polymerase chain reaction (PCR)
assays was extracted by heating bacterial suspensions for
10 min at 95°C. qnrA, blaCTX-M,and aadB were detected by
PCR with primers and annealing temperatures described in
the Table. The outbreak strain carried an integron contain-
ing an aadB gene encoding aminoglycoside resistance
(17). Primers were developed to detect aadB gene and the
downstream 3′-conserved segment (CS) of the integron in
the same PCR (aadB-3′CS). PCR assays were performed
for 30 or 35 cycles. The AmpC PCR tests were performed
as described earlier, except that a single PCR format was
used (18). 
The  blaCTX-M  gene from E. cloacae 02-477 was
sequenced by using CTX-M-9 group sequence primers
(Table). The flanking regions of the qnrA gene and the
blaCTX-M-9 gene were determined by using a PCR and DNA
sequencing strategy based on the sequences from In7,
In36, In37, In60, and an integron from E. coli O159
(5,9,19–22). To confirm that the gene cassettes were part
of a complex integron with qnrA or blaCTX-M-9, we used the
Expand Long Template PCR system (Roche, Woerden, the
Netherlands) that employed primers to amplify sequences
between the qnrA or blaCTX-M-9 and the possible gene cas-
settes. All amplified products were (partly) sequenced for
confirmation. Sequencing was performed with Qiagen
Quick (Qiagen, Westburg b.v., Leusden, the Netherlands)
purified PCR products by using the BigDye Terminator
v1.1 Cycle Sequencing Ready Reaction Kit and a 3100
capillary DNA sequencer (Applied Biosystems,
Nieuwerkerk a/d Yssel, the Netherlands). 
Conjugation Experiments 
For conjugation experiments, an E. coli K12 and a
tobramycin-susceptible clinical E. cloacae (03-702) isolate
of PFGE cluster IA were used as recipients. An E. cloacae
(02-477) belonging to PFGE cluster I was used as donor.
Conjugation was performed as described (23). MacConkey
agar plates containing tobramycin (8 µg/mL) were used for
counter selection, and transconjugants were selected on
colony form. Conjugation was confirmed by a qnrA-spe-
cific PCR. Secondly, transconjugant E. coli C02-477Awas
used as a donor for qnrA-negative  E. cloacae 03-702
belonging to cluster IA. Transconjugants were selected by
using 15 µg/mL ampicillin-clavulanic acid and 5 µg/mL
tobramycin. Transconjugants were characterized as
described above.
Detecting Resistance Genes on Plasmid 
by Southern Hybridization 
Plasmids were isolated with the Qiagen Plasmid Maxi
Kit (Qiagen). Plasmid DNA was separated on 1% PFGE
agarose (Bio-Rad Laboratories, Richmond, CA, USA) in
0.5× Tris-borate-EDTA, 0.05 mmol/L thiourea buffer at
14°C in CHEF DR-II apparatus (Bio-Rad). Run time was
22 h with a voltage of 6 V/cm and a linearly ramped pulse
time of 30 to 70 s. The DNA was blotted and hybridized.
The probes were PCR amplification products obtained
with primers used to detect aadB-3′-CS, blaCTX-M-9, and
qnrA genes (Table). Products were labeled with the
AlkPhosDirect Reaction Kit (Amersham Biosciences) and
detected with CPD-Star (Amersham Biosciences).
Results
qnrA1 in Outbreak Strain
For 78 (94%) of the 83 E. cloacae isolates in cluster I
(outbreak strain), the qnrA-specific PCR was positive. To
confirm results from the PCR, 2 fragments were
sequenced. The obtained sequences were identical to the
published sequence of qnrA1 (GenBank accession no.
AY070235).
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break isolates were resistant or intermediate resistant to
ciprofloxacin (43% resistant, 43% intermediate resistant),
100% were resistant to tobramycin, 63% to gentamicin,
2% to amikacin, 100% to ceftriaxone, 12% to trimetho-
prim-sulfamethoxazole, and 0% to carbapenems. Atotal of
81 (98%) of the 83 isolates harbored an aadB containing
integron.
IEF showed the presence of a β-lactamase with a pI of
≈8.2, which suggested the presence of either an AmpC β-
lactamase or a CTX-M type extended-spectrum β-lacta-
mase. No AmpC-specific amplification products were
obtained. Eighty-two (99%) of the 83 isolates harbored a
blaCTX-M gene. DNA sequencing showed the presence of
blaCTX-M-9.
The plasmid (pQC) of conjugant E. coli C02-477Awas
isolated, and its size was estimated at 180 kb by agarose
gel electrophoresis. Southern blotting that used specific
probes confirmed that pQC contained the qnrA1 gene, the
blaCTX-M-9 gene, and the integron with an aadB gene cas-
sette (data not shown). Sequences flanking the qnrA1 and
blaCTX-M-9  genes were comparable with 3 previously
described class 1 integrons (Figure 1). The first integron
(In-UMCU-1 accession no. AY987395), containing the
qnrA1 gene, had the same additional structures as In36,
orf513, qnrA1, ampR, plus a second copy of the 3′-con-
served segment. The In36 integron contained the gene cas-
settes drf16 and aadA2, while In-UMCU-1 contained only
the aadB gene cassette. In addition, the DNA sequences
between the second sul1 gene and orf5 (bp 9606–9624 of
In36) differed from the sequence of In-UMCU-1 (5). The
second integron (In-UMCU-2, accession no. DQ108615),
which contained blaCTX-M-9, was comparable to In60, but
In60 contained the drf16 and aadA2 gene cassettes, while
In-UMCU-2 contained the aadB gene cassette (21). The
third integron (In-UMCU-3, accession no. DQ019420),
which contained the gene cassettes sat, psp, and aadA2,
was described previously in an enterotoxigenic E. coli
O159 isolated in Japan (22). PCR amplification of the
aadA2 gene of the donor, recipient, and transconjugants
indicated that this third integron was also located on pQC. 
Evidence for Transfer of qnrA in vitro 
In vitro conjugation experiments showed that pQC
could be transferred both from and to the outbreak strain
(Figure 2). pQC was successfully transferred from
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transconjugant E. coli was subsequently used as donor to
transfer pQC to a type IA E. cloacae (03-702), which
resulted in a successful transfer of pQC. pQC conferred
increased ciprofloxacin MICs (from 6- to 10-fold) and
resistance to tobramycin, tetracycline, and ceftriaxone to
the transconjugants (Figure 2). Acquisition and loss of
pQC were associated with 2 changes in the PFGE pattern.
Evidence for Transfer of qnrA1 in vivo
Different species or strains collected from the same
patient harbored the same pQC. From 22 of the 53 patients
with an outbreak strain, 35 other tobramycin-resistant,
gram-negative clinical isolates were available. Eleven dif-
ferent strains obtained from 11 patients were positive for
qnrA1, blaCTX-M-9, andaadB-3′-CS. These comprised 4 dif-
ferent species: C. freundii (n = 1), Enterobacter aerogenes
(n = 1), E. coli (n = 7), and K. pneumoniae (n = 2). Plasmid
isolation from 6 E. coli and 1 K. pneumoniae yielded a
plasmid of the same size as the pQC in the outbreak strain.
Because of its large size and possibly a very low copy
number, only small amounts of plasmid DNAcould be iso-
lated. These amounts were insufficient to perform further
comparative analyses by restriction fragment analysis or
Southern blotting.
Some E. cloacae strains with a strong epidemiologic
link to the outbreak strain were also pQC positive. All iso-
lates belonging to clusters III, VII, and VIII contained pQC
as well as 5 E. cloacae isolates with a unique genotype.
Plasmid isolation of 3 strains again showed a plasmid of
the same size as the outbreak pQC. Three of the 5 unique
isolates were obtained from patients who also harbored the
outbreak strain.
The qnrA gene, the aadB-containing integron, and the
blaCTX-M-9 could not be detected in PFGE cluster IA, which
is closely related to the outbreak strain (Figure 3). The loss
of these genes was associated with increased susceptibility
to ciprofloxacin, tobramycin, ceftriaxone, and tetracycline.
In addition, an identical change in the PFGE pattern was
observed, as in the in vitro experiments. These results sug-
gest that the host may lose pQC in vivo. 
qnrA1 Recent Emergence as Clinical Problem
pQC was not found in isolates obtained from patients
without an epidemiologic link to the outbreak. No qnrA1
gene was detected in any of 83 aminoglycoside-resistant
gram-negative organisms (44 E. coli, 19 K. pneumoniae, 4
Proteus mirabilis, 2 Klebsiella oxytoca, 2 E. cloacae, 1
Enterobacter  sp., 7 C. freundii, 4 Serratia marcescens)
obtained from 74 patients admitted to wards not involved
in the outbreak during the outbreak period. Neither was
qnrA1 detected in any of the 269 UMCU isolates or the 84
community isolates.
Only 1 qnrA1-positive isolate was found in the 514
European isolates. This qnrA1-positive isolate was an E.
cloacae organism isolated in 1999 at a surgical ward at
UMCU that belonged to cluster III. The other 2 cluster III
isolates were isolated at the same surgical ward during the
outbreak period.
Discussion
We report a nosocomial outbreak with an R-
plasmid–encoded  qnrA1 gene. This plasmid (pQC) was
first detected in an E. cloacae isolated in 1999 and subse-
quently in another E. cloacae strain that caused a large out-
break in our hospital, starting in 2001. Strong evidence is
provided that this outbreak strain was the source from
which pQC disseminated to other strains of the same
species and other species by horizontal gene transfer. The
qnrA1 gene was not detected in any of the hospital isolates
(1994–2003) tested without an epidemiologic link to the
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Figure 1. Schematic presentation of integrons on pQC compared
with previously described integrons (5,9,19,21,22). The black dou-
ble-pointed arrows indicate the product amplified with an Expand
Long Template PCR system (Roche, Woerden, the Netherlands),
demonstrating a link between the qnrA and blaCTX-M-9 genes and
their respective integrons.
Figure 2. Pulsed-field gel electrophoresis (PFGE) patterns, sus-
ceptibility patterns, and key resistance genes for recipient and
transconjugants in in vitro conjugation experiments. Boxes denote
the area of variability in the PFGE patterns between isolates with
and without pQC. CIP, ciprofloxacin; TOB, tobramycin; CRO, cef-
triaxone; TET, tetracycline. *Escherichia coli transformant served
as donor for Enterobacter cloacae 02-0702.outbreak strain, indicating that qnrA1 is a new emerging
resistance trait in our hospital. 
pQC contained 3 different class 1 integrons. One inte-
gron was identical to an integron detected in an E. coli
O159 from Japan (22). The 2 other integrons were complex
integrons, In-UMCU-1 and In-UMCU-2, which were not
described previously. Complex integrons are composed of
a 5′-CS, gene cassettes, 3′-CS,  qac∆E,  sulI, additional
genes, qac∆E, and sulI. These additional genes differ from
gene cassettes by lacking a 59-bp element and having their
own promoter (24). The qnrA1 gene in In-UMCU-1 was
also present as an additional gene, as was the case for the 3
previous characterized qnrA1 genes in In36, In37, and the
complex integron of pQR1 (5,9). The sequences of these
genes were identical for In-UMCU-1, In 36, and In37, and
slightly different for the integron on pQR1. The gene cas-
sette content of the 4 integrons, however, was different,
although all 4 possessed a gene encoding aminoglycoside
resistance. All qnrA1-positive isolates reported in the liter-
ature also show resistance to cephalosporins (1,4–9,25–27).
Therefore,  qnrA1  seems to be closely associated with
resistance to cephalosporins and aminoglycosides. How
these comparable but different complex integrons arose is
unclear. Either the same additional genes became associat-
ed with different integrons or the gene cassettes in an orig-
inal complex integron were exchanged. 
Our study confirmed previous findings that the pres-
ence of qnrA1 does not necessarily lead to MICs above
Clinical and Laboratory Standards Institute breakpoints for
resistance to ciprofloxacin (1,3,7,25). Therefore, the pres-
ence of qnrA1 had no therapeutic consequences for the
patients from whom these isolates were obtained.
However, the increased MIC may provide the host bacteri-
um a selective advantage in an environment of low con-
centrations of quinolones, increasing the bacterial numbers
and therefore the absolute chance of a chromosomal muta-
tion encoding resistance (7,25). The presence of a qnrA-
carrying plasmid might even enhance the mutation rate
encoding quinolone resistance (1). Furthermore, acquisi-
tion of qnrA by a host bacterium that already contains
quinolone resistance mechanisms may raise MICs above
the LCSI breakpoints (25,28,29). As shown in this study,
the same plasmid may cause fluctuation in susceptibility in
MICs in different recipients because of variation in porin
expression or mutations in the gyrase or efflux pump-
encoding genes (2). 
In conclusion, in a hospital setting the qnrA gene is
advantageous for the host bacterium. Because of this
gene’s location on promiscuous R-plasmids, it is likely to
emerge worldwide.
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